123 related articles for article (PubMed ID: 35176281)
1. Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity.
Shi S; Ma B; Sun F; Qu C; Li G; Shi D; Liu W; Zhang H; An H
J Biol Chem; 2022 Mar; 298(3):101731. PubMed ID: 35176281
[TBL] [Abstract][Full Text] [Related]
2. Theaflavin binds to a druggable pocket of TMEM16A channel and inhibits lung adenocarcinoma cell viability.
Shi S; Ma B; Sun F; Qu C; An H
J Biol Chem; 2021 Sep; 297(3):101016. PubMed ID: 34329684
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing and molecular mechanisms of the antihypertensive drug candesartan as a TMEM16A channel inhibitor.
Ji Q; Shi S; Ma B; Zhang W; An H; Guo S
Int J Biol Macromol; 2023 Apr; 235():123839. PubMed ID: 36842737
[TBL] [Abstract][Full Text] [Related]
4. Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effects.
Guo S; Chen Y; Pang C; Wang X; Shi S; Zhang H; An H; Zhan Y
J Cell Physiol; 2019 Jun; 234(6):8698-8708. PubMed ID: 30370542
[TBL] [Abstract][Full Text] [Related]
5. Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy.
Guo S; Chen Y; Shi S; Wang X; Zhang H; Zhan Y; An H
Pharmacol Res; 2020 May; 155():104721. PubMed ID: 32097750
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TMEM16A Ca
Zhang X; Zhang G; Zhai W; Zhao Z; Wang S; Yi J
Pharmacol Res; 2020 Jun; 156():104763. PubMed ID: 32201246
[TBL] [Abstract][Full Text] [Related]
7. TMEM16A-inhibitor loaded pH-responsive nanoparticles: A novel dual-targeting antitumor therapy for lung adenocarcinoma.
Guo S; Qiu L; Chen Y; Wang X; Ma B; Qu C; Cui J; Zhang H; Xing C; Zhan Y; An H
Biochem Pharmacol; 2020 Aug; 178():114062. PubMed ID: 32492446
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of daidzein on the calcium-activated chloride channel TMEM16A and its anti-lung adenocarcinoma activity.
Wang X; Hao A; Song G; Elena V; Sun Y; Zhang H; Zhan Y; An H; Chen Y
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127261. PubMed ID: 37802433
[TBL] [Abstract][Full Text] [Related]
9. TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.
Guo S; Bai X; Shi S; Deng Y; Kang X; An H
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681590
[TBL] [Abstract][Full Text] [Related]
10. Benzophenanthridine alkaloids suppress lung adenocarcinoma by blocking TMEM16A Ca
Zhang G; Zhu L; Xue Y; Zhao Z; Li H; Niu Z; Wang X; Chen P; Zhang J; Zhang X
Pflugers Arch; 2020 Oct; 472(10):1457-1467. PubMed ID: 32683500
[TBL] [Abstract][Full Text] [Related]
11. Cepharanthine, a novel selective ANO1 inhibitor with potential for lung adenocarcinoma therapy.
Zhang X; Zhang G; Zhao Z; Xiu R; Jia J; Chen P; Liu Y; Wang Y; Yi J
Biochim Biophys Acta Mol Cell Res; 2021 Nov; 1868(12):119132. PubMed ID: 34450215
[TBL] [Abstract][Full Text] [Related]
12. Identification of a druggable pocket of the calcium-activated chloride channel TMEM16A in its open state.
Shi S; Ma B; Ji Q; Guo S; An H; Ye S
J Biol Chem; 2023 Jun; 299(6):104780. PubMed ID: 37142220
[TBL] [Abstract][Full Text] [Related]
13. TMEM16A Ca
Suzuki T; Yasumoto M; Suzuki Y; Asai K; Imaizumi Y; Yamamura H
Mol Pharmacol; 2020 Jul; 98(1):61-71. PubMed ID: 32358165
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma.
Guo S; Bai X; Liu Y; Shi S; Wang X; Zhan Y; Kang X; Chen Y; An H
Front Pharmacol; 2021; 12():643489. PubMed ID: 33935737
[No Abstract] [Full Text] [Related]
15. Molecular mechanism of CaCC
Shi S; Guo S; Chen Y; Sun F; Pang C; Ma B; Qu C; An H
Arch Biochem Biophys; 2020 Nov; 695():108650. PubMed ID: 33132191
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of ion channel protein TMEM16A regulated by natural product of narirutin for lung cancer adjuvant treatment.
Shi S; Bai X; Ji Q; Wan H; An H; Kang X; Guo S
Int J Biol Macromol; 2022 Dec; 223(Pt A):1145-1157. PubMed ID: 36400205
[TBL] [Abstract][Full Text] [Related]
17. Natural Compound Allicin Containing Thiosulfinate Moieties as Transmembrane Protein 16A (TMEM16A) Ion Channel Inhibitor for Food Adjuvant Therapy of Lung Cancer.
Bai X; Cheng Y; Wan H; Li S; Kang X; Guo S
J Agric Food Chem; 2023 Jan; 71(1):535-545. PubMed ID: 36574498
[TBL] [Abstract][Full Text] [Related]
18. Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma.
Guo S; Bai X; Shi S; Li S; Liu X; An H; Kang X
Biomed Pharmacother; 2022 Sep; 153():113392. PubMed ID: 35834992
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of allosteric activation of TMEM16A/ANO1 channels by a commonly used chloride channel blocker.
Ta CM; Adomaviciene A; Rorsman NJ; Garnett H; Tammaro P
Br J Pharmacol; 2016 Feb; 173(3):511-28. PubMed ID: 26562072
[TBL] [Abstract][Full Text] [Related]
20. Matairesinoside, a novel inhibitor of TMEM16A ion channel, loaded with functional hydrogel for lung cancer treatment.
Wang Z; Geng R; Chen Y; Qin J; Guo S
Int J Biol Macromol; 2024 Apr; 264(Pt 2):130618. PubMed ID: 38447844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
